Category Archives: Public Policy

Latest From Public Policy

Tick Size Pilot Program: A Few Pennies Make a Big Difference

72263479

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program that will begin next year. We issued this statement, praising the SEC for finalizing this program, which could improve liquidity and enhance capital formation for emerging biotech companies. Under current SEC rules, all securities on the public market are priced in $0.01 increments known as “tick sizes.” The switch to the standard tick size of a penny was enacted in 2000 Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

IP Sessions at the 2015 BIO International Convention

BIO International Convention

This year’s BIO International Convention will be host to educational sessions on the latest issues in the biotech IP sector.  The world’s largest biotechnology gathering, the convention offers attendees the chance to come together to hear, discuss, and learn about current issues affecting the biotech community. Here’s a look at the Intellectual Property Track at this year’s convention: Sessions* Intellectual Property Opening Plenary Antibody Therapeutics: May I Have Them All? The Impact of USPTO Inter Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”

CSBI-logo

Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set of tax reform proposals developed by the Coalition of Small Business Innovators (CSBI), of which BIO is a member. The proposals would increase investment and employment at small, research intensive companiesby allowing investors to take advantage of passive losses and research credits generated by the company. They would also allow companies to carry net operating losses forward to future years Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Deputy General Counsel Testifies on Patent Reform

patent

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front of the U.S. Senate Judiciary Committee regarding proposed reforms to the current U.S. patent system. The hearing was a chance for the Judiciary committee to listen to experts on what should be done to halt misuse of the patent system. In his remarks, Mr. Sauer noted that while BIO appreciates efforts by Congress to curb patent troll abuses, some of Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , ,

Blue Ribbon Study Panel Examines Surveillance and Detection Issues in Biodefense

Jim Greenwood

The Blue Ribbon Study Panel on Biodefense held the third of four meetings on Thursday, March 12, 2015. The goal of the Panel is to evaluate the United States’ level of preparedness for a natural or deliberate biological or chemical event and to develop actionable recommendations toward the aim of preparedness. The Blue Ribbon Study Panel on Biodefense will build off the work previously done by the 9/11 Commission and the Weapons of Mass Destruction Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: ,